Zobrazeno 1 - 10
of 12
pro vyhledávání: '"D Gonzalez Vaquero"'
Autor:
D Gonzalez Vaquero, C Redondo Galán, M Ferris Villanueva, M. D. Rivas Rodríguez, JF Rangel Mayoral
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance Tocilizumab is an immunosuppressive agent which has demonstrated high efficacy in clinical trials for the treatment of coronavirus because its mechanism of action seems to inhibit the inflammatory cascade Aim and objectives
Autor:
C Redondo Galán, R Medina Comas, Rivas Rodríguez, M Ferris Villanueva, D Gonzalez Vaquero, JF Rangel Mayoral
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance With the arrival of the global SARS-CoV-2 pandemic, hospital pharmacy services (HPS) have had to adapt to emerging needs. One of these measures has been the sending of medicines to vulnerable patients who, due to their patho
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance The roles of hospital pharmacists have been expanded from dispensing to patient care. Establishing interprofessional collaboration between pharmacists and other specialists significantly improves the quality of patient care.
Autor:
P Acosta Robles, A Martos Rosa, D Gonzalez Vaquero, J Urda Romacho, M Aznar Garcia, F Avila Cabrera, MA Castro Vida
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Malaria is a parasitic disease caused by the parasite Plasmodium falciparum that is transmitted through the bite of infected Anopheles female mosquitoes. It is a deadly disease that requires diagnosis and urgent treatment. The treatment is
Autor:
A Martos Rosa, P Acosta Robles, J Urda Romacho, D Gonzalez Vaquero, G Gómiz Rodriguez, E Manzano López
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Rituximab is a monoclonal antibody indicated in Spain in adults with non-Hodgkin’s lymphoma, chronic lymphatic leukaemia, rheumatoid arthritis and granulomatosis with polyangiitis and microscopic polyangiitis. Purpose To evaluate the use
Autor:
JA Morales Molina, P Acosta Robles, A Martos Rosa, M Aznar Garcia, JE Martinez De La Plata, D Gonzalez Vaquero, F Avila Cabrera
Publikováno v:
Eur J Hosp Pharm
Background Cutaneous diphtheria is a skin infection caused by toxigenic and non-toxigenic strains of Corynebacterium diphtheriae. It is characterised by chronic nonhealing ulcers. Diagnosis may be delayed because it is a rare infection in developed c
Autor:
J Urda Romacho, P Acosta Robles, A Martos Rosa, M Aznar Garcia, D Gonzalez Vaquero, A Jofre Peralta, JA Morales Molina, MACastro Vida, JE Martinez De La Plata, F Avila Cabrera
Publikováno v:
Eur J Hosp Pharm
Background Darunavir/cobicistat (DRV/COB) is the first fixed combination inhibitor of protease. Both are metabolised by the cytochrome CYP3A4, the reason why they are susceptible to present a multitude of drug interactions (DI). Purpose To describe t
Autor:
JB Montoro Ronsano, R. Albertos Martell, D. Berlana, S Garcia Garcia, R. Burgos Peláez, P. Sanchez-Sancho, C. Puiggros, D. Gonzalez Vaquero, I. Cardona Pascual
Publikováno v:
Clinical Nutrition. 38:S63-S64
Autor:
D Gonzalez Vaquero, JM Fernández Martín, MA Castro Vida, José Antonio Morales-Molina, J Urda Romacho, P Acosta Robles
Publikováno v:
European Journal of Hospital Pharmacy. 23:A178.3-A179
Background Determination of the plasma concentration of free phenytoin (C p FL) could improve seizure control and prevent adverse effects. Purpose To evaluate the safety profile of patients treated with phenytoin using C p FL. Material and methods Pr
Autor:
JM Fernández Martín, D Gonzalez Vaquero, A Martos Rosa, M Gimeno Jordá, JA Morales Molina, J Urda Romacho, A Fayet Pérez
Publikováno v:
European Journal of Hospital Pharmacy. 22:A81.3-A82
Background Rilpivirine/Emtricitabine/Tenofovir (RPV/FTC/TDF) is a single tablet regimen recommended for treatment-naive HIV patients with baseline viral load (VL) 1 Purpose To analyse the usage profile, effectiveness and safety of RPV/FTC/TDF. Materi